性别选择有效吗?观察性研究

Narges R Ben Halim, Hamza Elmahaishi, Mohamed Said Elmahaishi
{"title":"性别选择有效吗?观察性研究","authors":"Narges R Ben Halim, Hamza Elmahaishi, Mohamed Said Elmahaishi","doi":"10.33425/2768-4598.1030","DOIUrl":null,"url":null,"abstract":"Sex selection is an option for couples who want to avoid passing a sex- linked genetic disease to their baby. For example, some females are carriers for over 350 X-linked diseases, even if the disease does not directly affect them. Hemophilia and Duchenne muscular dystrophy are examples of diseases that occur with a recessive gene on the X chromosome. Some choose the sex of their baby because of a personal preference like \"Family balancing.\" Many studies were done before to prefer one gender upon another. When we look at the statistics the chances of having a boy or a girl are almost the same and there is no medical evidence to suggest we can influence Design: Prospective randomized controlled study. Setting: The study was conducted at LAMIS Clinic for Obstetrics &amp; Gynecology from January 2015 to February 2022 and still continue up today. The study started after observation that use of cyclofert female capsules before conceptions leads to more probability to male sex embryos. Our study contains five thousand patients who received cyclofert female capsules at dose of two capsules per day for at least two months before conceptions. The data was compared with another one thousands patients who receive placebo. The two groups divided into three according to the age group. All patient included were on natural cycles and no ovulation inductions used, irrespective of the parity. Objectives: To rule out that the observation which is noted that increase male gender embryos related to use of cyclofertfemal capsules or not. Results: The overall pregnancy rate irrespective of the age was 86.02% (4301/5000) &amp; 66.6% (666/1000) for the cyclofert group and the placebo group respectively. Overall abortion rate for cyclofert group was 1.4% (60/4301) while 9.3% (62/666) for placebo group. 89.69% (3804/4241) of the total pregnancy were male gender in cyclofert Group, while at placebo group it was 41.23 % (249/604), (p<0.05 statistically significant). Conclusion: Gender selection could be work by non-invasive, not expensive, effective, affordable, and available without complication method by giving cyclofert female capsules, which is, increases the pregnancy rate, reduces the rate of abortion and increases the male gender embryos. Although, there is no guarantee that the baby will actually be one sex or the other, but cyclofertfemal capsules can influence what type of sperm cell will reach an ovum, and fertilize it. Therefore, yes, male gender selection may be technically possible.","PeriodicalId":486907,"journal":{"name":"Archives of Clinical Trials","volume":"40 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Does gender selection works? An observational study\",\"authors\":\"Narges R Ben Halim, Hamza Elmahaishi, Mohamed Said Elmahaishi\",\"doi\":\"10.33425/2768-4598.1030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sex selection is an option for couples who want to avoid passing a sex- linked genetic disease to their baby. For example, some females are carriers for over 350 X-linked diseases, even if the disease does not directly affect them. Hemophilia and Duchenne muscular dystrophy are examples of diseases that occur with a recessive gene on the X chromosome. Some choose the sex of their baby because of a personal preference like \\\"Family balancing.\\\" Many studies were done before to prefer one gender upon another. When we look at the statistics the chances of having a boy or a girl are almost the same and there is no medical evidence to suggest we can influence Design: Prospective randomized controlled study. Setting: The study was conducted at LAMIS Clinic for Obstetrics &amp; Gynecology from January 2015 to February 2022 and still continue up today. The study started after observation that use of cyclofert female capsules before conceptions leads to more probability to male sex embryos. Our study contains five thousand patients who received cyclofert female capsules at dose of two capsules per day for at least two months before conceptions. The data was compared with another one thousands patients who receive placebo. The two groups divided into three according to the age group. All patient included were on natural cycles and no ovulation inductions used, irrespective of the parity. Objectives: To rule out that the observation which is noted that increase male gender embryos related to use of cyclofertfemal capsules or not. Results: The overall pregnancy rate irrespective of the age was 86.02% (4301/5000) &amp; 66.6% (666/1000) for the cyclofert group and the placebo group respectively. Overall abortion rate for cyclofert group was 1.4% (60/4301) while 9.3% (62/666) for placebo group. 89.69% (3804/4241) of the total pregnancy were male gender in cyclofert Group, while at placebo group it was 41.23 % (249/604), (p<0.05 statistically significant). Conclusion: Gender selection could be work by non-invasive, not expensive, effective, affordable, and available without complication method by giving cyclofert female capsules, which is, increases the pregnancy rate, reduces the rate of abortion and increases the male gender embryos. Although, there is no guarantee that the baby will actually be one sex or the other, but cyclofertfemal capsules can influence what type of sperm cell will reach an ovum, and fertilize it. Therefore, yes, male gender selection may be technically possible.\",\"PeriodicalId\":486907,\"journal\":{\"name\":\"Archives of Clinical Trials\",\"volume\":\"40 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Clinical Trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33425/2768-4598.1030\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33425/2768-4598.1030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

性别选择是那些想要避免将与性别相关的遗传疾病传给孩子的夫妇的一个选择。例如,一些女性是350多种x相关疾病的携带者,即使这种疾病并不直接影响她们。血友病和杜氏肌营养不良是与X染色体上的隐性基因有关的疾病的例子。有些人选择孩子的性别是出于个人偏好,比如“家庭平衡”。在此之前,很多研究都倾向于一种性别。当我们看统计数据时,生男孩或女孩的几率几乎是一样的,没有医学证据表明我们可以影响设计:前瞻性随机对照研究。环境:本研究在LAMIS产科诊所进行;从2015年1月到2022年2月,一直持续到今天。这项研究是在观察到怀孕前使用cyclofert女性胶囊会导致更大的可能性产生男性胚胎后开始的。我们的研究包含5000名患者,他们在怀孕前至少两个月每天服用两粒cyclofert女性胶囊。这些数据与另外1000名接受安慰剂的患者进行了比较。两组按年龄组分为三组。所有患者均为自然周期,无论胎次如何,均未使用促排卵剂。目的:排除已注意到的雄性胚胎增加与使用环胎胶囊有关的观察结果。结果:不考虑年龄的总妊娠率为86.02% (4301/5000);cyclofert组和安慰剂组分别为66.6%(666/1000)。cyclofert组总流产率为1.4%(60/4301),安慰剂组为9.3%(62/666)。环硝子组总妊娠中男性占89.69%(3804/4241),安慰剂组为41.23%(249/604),差异有统计学意义(p < 0.05)。结论:给予cyclofert女性胶囊进行性别选择是一种无创、价廉、有效、经济、无并发症的方法,可提高妊娠率,降低流产率,增加男性胚胎。虽然,并不能保证宝宝是一种性别还是另一种性别,但是环精胶囊可以影响哪种类型的精子细胞会到达卵子,并使其受精。因此,是的,男性性别选择在技术上是可能的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Does gender selection works? An observational study
Sex selection is an option for couples who want to avoid passing a sex- linked genetic disease to their baby. For example, some females are carriers for over 350 X-linked diseases, even if the disease does not directly affect them. Hemophilia and Duchenne muscular dystrophy are examples of diseases that occur with a recessive gene on the X chromosome. Some choose the sex of their baby because of a personal preference like "Family balancing." Many studies were done before to prefer one gender upon another. When we look at the statistics the chances of having a boy or a girl are almost the same and there is no medical evidence to suggest we can influence Design: Prospective randomized controlled study. Setting: The study was conducted at LAMIS Clinic for Obstetrics & Gynecology from January 2015 to February 2022 and still continue up today. The study started after observation that use of cyclofert female capsules before conceptions leads to more probability to male sex embryos. Our study contains five thousand patients who received cyclofert female capsules at dose of two capsules per day for at least two months before conceptions. The data was compared with another one thousands patients who receive placebo. The two groups divided into three according to the age group. All patient included were on natural cycles and no ovulation inductions used, irrespective of the parity. Objectives: To rule out that the observation which is noted that increase male gender embryos related to use of cyclofertfemal capsules or not. Results: The overall pregnancy rate irrespective of the age was 86.02% (4301/5000) & 66.6% (666/1000) for the cyclofert group and the placebo group respectively. Overall abortion rate for cyclofert group was 1.4% (60/4301) while 9.3% (62/666) for placebo group. 89.69% (3804/4241) of the total pregnancy were male gender in cyclofert Group, while at placebo group it was 41.23 % (249/604), (p<0.05 statistically significant). Conclusion: Gender selection could be work by non-invasive, not expensive, effective, affordable, and available without complication method by giving cyclofert female capsules, which is, increases the pregnancy rate, reduces the rate of abortion and increases the male gender embryos. Although, there is no guarantee that the baby will actually be one sex or the other, but cyclofertfemal capsules can influence what type of sperm cell will reach an ovum, and fertilize it. Therefore, yes, male gender selection may be technically possible.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信